Scholar Rock Holding (SRRK) Shareholder's Equity Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.63% |
| Dec 31, 2025 | -33.41% |
| Sep 30, 2025 | 209.35% |
| Jun 30, 2025 | 74.59% |
| Mar 31, 2025 | 70.89% |
| Dec 31, 2024 | 63.68% |
| Sep 30, 2024 | -52.77% |
| Jun 30, 2024 | -34.02% |
| Mar 31, 2024 | -20.07% |
| Dec 31, 2023 | -13.46% |
| Sep 30, 2023 | -42.83% |
| Jun 30, 2023 | -38.54% |
| Mar 31, 2023 | 33.47% |
| Dec 31, 2022 | 51.23% |
| Sep 30, 2022 | 56.61% |
| Jun 30, 2022 | 52.09% |
| Mar 31, 2022 | -28.78% |
| Dec 31, 2021 | -34.01% |
| Sep 30, 2021 | 197.35% |
| Jun 30, 2021 | 163.66% |
| Mar 31, 2021 | 143.84% |
| Dec 31, 2020 | 130.97% |
| Sep 30, 2020 | -48.29% |
| Jun 30, 2020 | -36.28% |
| Mar 31, 2020 | 1.15% |
| Dec 31, 2019 | 5.89% |
| Sep 30, 2019 | 19.00% |
| Jun 30, 2019 | 15.54% |
| Mar 31, 2019 | 257.47% |
| Dec 31, 2018 | 299.21% |